Pharmacokinetic Variability of Daptomycin during Prolonged Therapy for Bone and Joint Infections

The interindividual and intraindividual variabilities in daptomycin pharmacokinetics were investigated in 23 patients (69 pharmacokinetic profiles) who were treated for several months for bone and joint infections. Population daptomycin clearance was significantly influenced by renal function and was significantly higher in male than in female patients. We observed significant intraindividual changes in daptomycin clearance, which were uncorrelated with changes in renal function, suggesting that therapeutic drug monitoring is important in patients receiving prolonged daptomycin therapy.

Keywords

OS ARTICULATION HUMAINE

Domains

Biomechanics [physics.med-ph]

Fichier principal

ris00000075.pdf (555.41 Ko)

Origin	Publisher files allowed on an open archive

Ifsttar Cadic : Connect in order to contact the contributor

https://hal.science/hal-01464943

Submitted on : Wednesday, February 22, 2017-11:21:52 AM

Last modification on : Wednesday, July 3, 2024-9:00:06 AM

Long-term archiving on : Tuesday, May 23, 2017-1:23:36 PM

Dates and versions

hal-01464943 , version 1 (22-02-2017)

Identifiers

HAL Id : hal-01464943 , version 1
DOI : 10.1128/AAC.02597-15

Cite

Sylvain Goutelle, Sandrine Roux, Marie-Claude Gagnieu, Florent Valour, Sebastien Lustig, et al.. Pharmacokinetic Variability of Daptomycin during Prolonged Therapy for Bone and Joint Infections. Antimicrobial Agents and Chemotherapy, 2016, 60 (5), pp. 3148-3151. ⟨10.1128/AAC.02597-15⟩. ⟨hal-01464943⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM UNIV-ST-ETIENNE ENS-LYON HCL CNRS UNIV-LYON1 IFSTTAR BIOENVIS LBBE CIRI LBMC UDL CIRI-P-DOUBLET-S-JARRAUD-LEGIOPATH CIRI-F-VANDENESCH-STAPATH UNIV-EIFFEL

146 View

102 Download